𝔖 Bobbio Scriptorium
✦   LIBER   ✦

APIXABAN FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS: DATA FROM THE AMPLIFY TRIAL

✍ Scribed by Agnelli, G.; Buller, H.R.; Cohen, A.; Curto, M.; Gallus, A.S.; Pak, R.; Raskob, G.E.; Weitz, J.I.; Yamabe, T.

Book ID
127168163
Publisher
Pulsus Group Inc
Year
2014
Tongue
English
Weight
196 KB
Volume
30
Category
Article
ISSN
0828-282X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Anticoagulation for the initial treatmen
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer : A systematic review
✍ Elie A. Akl; Sandeep Rohilla; Maddalena Barba; Francesca Sperati; Irene Terrenat πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 312 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. The authors compared the relative efficacy and safety of low‐ molecular‐weight heparin (LMWH) and unfractionated heparin (UFH) for the initial treatment of venous thromboembolism (VTE) between patients with and without cancer. ## METHODS. By using Cochrane methodology